• Oct 30, 2025

Asset manager 21Shares has filed with the US Securities and Exchange Commission (SEC) to launch a Hyperliquid (HYPE) Exchange-Traded Fund (ETF).

Read More
  • Oct 23, 2025

Hyperliquid Strategies, a pending merged entity involving Nasdaq-listed Sonnet BioTherapeutics and Rorschach I LLC, has filed an S-1 registration statement with the US Securities and Exchange Commission (SEC) to raise up to $1 billion.

Read More
  • Oct 20, 2025

The native token of the Hyperliquid decentralized exchange, HYPE, is showing signs of recovery, climbing back to the critical 200-day Exponential Moving Average (EMA) after three straight days of gains.

Read More
  • Oct 15, 2025

The crypto market is facing significant renewed selling pressure, resulting in $655 million in total liquidations over the last 24 hours.

Read More
  • Oct 13, 2025

Hyperliquid (HYPE) is scheduled to activate its major protocol upgrade, Hyperliquid Improvement Proposal 3 (HIP-3), later today, October 13.

Read More
  • Oct 3, 2025

Aster (ASTER), a decentralized perpetuals exchange (DEX), has rapidly become the surprise heavyweight contender in the perps market, posing the first serious on-chain threat to the current leader, Hyperliquid.

Read More